Here's a statement of the obvious: The opinions expressed here are those of the participants, not those of the Mutual Fund Observer. We cannot vouch for the accuracy or appropriateness of any of it, though we do encourage civility and good humor.
Hmmm. I must be missing something. Looks like the ER goes from 0.63% to 0.62%. a DECREASE. I'm not subject to the $20 fee. I've got enough in there. (???????)
Alternative subject header: T. Rowe Price decreases fee on Spectrum Funds.
Currently, the expense ratio includes a significant "acquired fund fees and expenses" line item. For example, for PSILX, the current prospectus says this fee is 0.90%. The new prospectus (first link above) says that this fee will be reduced to less than 0.01%.
Instead of T. Rowe Price being paid through the acquired funds' fees, it is paid directly by the Spectrum funds. The net effect is no change in total expense ratios, but somewhat better transparency.
Comments
Currently, the expense ratio includes a significant "acquired fund fees and expenses" line item. For example, for PSILX, the current prospectus says this fee is 0.90%. The new prospectus (first link above) says that this fee will be reduced to less than 0.01%.
Instead of T. Rowe Price being paid through the acquired funds' fees, it is paid directly by the Spectrum funds. The net effect is no change in total expense ratios, but somewhat better transparency.
https://mutualfundobserver.com/discuss/discussion/comment/132712/#Comment_132712
Thanks for finding the original post concerning the upcoming vote on the fees.